First Trust Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
HI
PCM
MF
OP
First Trust Advisors's MNTA Position: Q3 2020 in Review
First Trust Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 95,757 shares — an estimated $3.19M sold.
First Trust Advisors first reported a position in MNTA in Q4 2014 and held it in 14 quarters. The position peaked at $4.17M in Q2 2015. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.
- First Trust Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- First Trust Advisors sold 95,757 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.19M.
- First Trust Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2014 and held it in 14 quarters.
- First Trust Advisors's Momenta Pharmaceuticals, Inc. position peaked at $4.17M in Q2 2015.
- 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.
Based on First Trust Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.